CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleRevenue is $1.81B, above the global median of $520.53M
- PositionPrice-to-book is 0.4×, lower than 95% of its Diagnostics & Research peers (median 2.05×)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.86BBRL556.48M · vs all stocks (USD)
Revenue (TTM)
9.32BBRL1.81B · vs all stocks (USD)
Profit Margin
-9.60%vs Diagnostics & Research peers
52-Week Change
104.00%vs all stocks
Market Capitalization
2.86BBRL556.48M · vs all stocks (USD)
Enterprise Value
9.19BBRL1.79B · vs all stocks (USD)
Forward P/E
9.65xvs Diagnostics & Research peers
Price to Sales (TTM)
0.2949xvs Diagnostics & Research peers
Price to Book (MRQ)
0.4005xvs Diagnostics & Research peers
Enterprise to Revenue
0.9860xvs Diagnostics & Research peers
Enterprise to EBITDA
6.61xvs Diagnostics & Research peers
Gross Margin
33.53%vs Diagnostics & Research peers
Profit Margin
-9.60%vs Diagnostics & Research peers
Operating Margin
10.77%vs Diagnostics & Research peers
Return on Assets (TTM)
2.30%vs Diagnostics & Research peers
Return on Equity (TTM)
-12.09%vs Diagnostics & Research peers
Revenue (TTM)
9.32BBRL1.81B · vs all stocks (USD)
Revenue per Share (TTM)
8.90BRLUpdated Aug 21, 2026Quarterly Revenue Growth
-9.80%vs Diagnostics & Research peers
Gross Profit (TTM)
2.89BBRL562.30M · vs all stocks (USD)
EBITDA (TTM)
2.10BBRL408.56M · vs all stocks (USD)
Net Income (TTM)
-892.90MBRL-173.61M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-41.91%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
435.63MBRL84.70M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
172.86MBRL33.61M · vs all stocks (USD)
5-Year Average Dividend Yield
1.09%vs all stocks
Payout Ratio
0.00%vs Diagnostics & Research peers
Minority Interest (Equity)
27.89MBRLFY2025 · Dec 31, 2025Revenue
11.17BBRLFY2025 · Dec 31, 2025Cost of Goods Sold
7.78BBRLFY2025 · Dec 31, 2025Gross Profit
3.39BBRLFY2025 · Dec 31, 2025Operating Income
1.01BBRL196.82M · vs all stocks (USD)
Pre-tax Income
-612.76MBRLFY2025 · Dec 31, 2025Income Tax Expense
521.96MBRLFY2025 · Dec 31, 2025Net Income
-1.14BBRLFY2025 · Dec 31, 2025EBIT
915.24MBRLFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.10BBRLFY2025 · Dec 31, 2025Selling, General & Administrative
2.38BBRLFY2025 · Dec 31, 2025Non-operating Interest Income
260.17MBRLFY2025 · Dec 31, 2025Non-operating Interest Expense
1.53BBRLFY2025 · Dec 31, 2025Minority Interests (P&L)
-16.96MBRLFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025Operating Cash Flow
594.53MBRLFY2025 · Dec 31, 2025Free Cash Flow
329.33MBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.67BBRLFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-612.76MBRLFY2025 · Dec 31, 2025Stock-based Compensation
21.05MBRLFY2025 · Dec 31, 2025Other Non-cash Items
1.76BBRLFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-661.58MBRLFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
91.70MBRLFY2025 · Dec 31, 2025Capital Expenditures
-265.20MBRLFY2025 · Dec 31, 2025Net Intangibles (CF)
-19.90MBRLFY2025 · Dec 31, 2025Net Acquisitions
1.66BBRLFY2025 · Dec 31, 2025Purchase of Investments
-79.17MBRLFY2025 · Dec 31, 2025Sale of Investments
129.95MBRLFY2025 · Dec 31, 2025Other Investing Activity
-76.92MBRLFY2025 · Dec 31, 2025Net Investing Cash Flow
1.37BBRLFY2025 · Dec 31, 2025Long-term Debt Issuance
4.35BBRLFY2025 · Dec 31, 2025Long-term Debt Payments
-4.19BBRLFY2025 · Dec 31, 2025Common Dividends Paid
-5.02MBRLFY2025 · Dec 31, 2025Other Financing Charges
-334.73MBRLFY2025 · Dec 31, 2025Net Financing Cash Flow
-175.08MBRLFY2025 · Dec 31, 2025Shares Outstanding
1.25BSharesUpdated Aug 21, 2026Float Shares
1.18BSharesUpdated Aug 21, 2026% Held by Insiders
5.94%vs all stocks
% Held by Institutions
86.97%vs all stocks
Total Cash (MRQ)
958.70MBRL186.40M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7670BRLUpdated Aug 21, 2026Total Debt (MRQ)
7.38BBRL1.43B · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.07xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.27xvs Diagnostics & Research peers
Book Value per Share (MRQ)
5.49BRLUpdated Aug 21, 2026Total Assets
18.56BBRL3.61B · vs all stocks (USD)
Total Current Assets
5.65BBRLFY2025 · Dec 31, 2025Total Liabilities
11.67BBRLFY2025 · Dec 31, 2025Total Non-current Assets
12.91BBRLFY2025 · Dec 31, 2025Total Non-current Liabilities
7.11BBRLFY2025 · Dec 31, 2025Total Current Liabilities
4.56BBRLFY2025 · Dec 31, 2025Cash
149.41MBRLFY2025 · Dec 31, 2025Cash Equivalents
2.52BBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.67BBRLFY2025 · Dec 31, 2025Accounts Receivable
2.10BBRLFY2025 · Dec 31, 2025Inventory
190.37MBRLFY2025 · Dec 31, 2025Accounts Payable
866.24MBRLFY2025 · Dec 31, 2025Short-term Debt
2.36BBRLFY2025 · Dec 31, 2025Long-term Debt
6.49BBRLFY2025 · Dec 31, 2025Common Stock (Book)
19.54BBRLFY2025 · Dec 31, 2025Retained Earnings
-4.03BBRLFY2025 · Dec 31, 2025Total Shareholders' Equity
6.89BBRL1.34B · vs all stocks (USD)
Treasury Stock
79.14MBRLFY2025 · Dec 31, 202552-Week Low
1.22BRLUpdated Aug 21, 202652-Week High
4.77BRLUpdated Aug 21, 202652-Week Change
104.00%vs all stocks
50-Day MA
2.69BRLUpdated Aug 21, 2026200-Day MA
3.31BRLUpdated Aug 21, 2026Avg 10-Day Volume
1.31MSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.08MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-0.7100BRLUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.4×, lower than 95% of its Diagnostics & Research peers (median 2.05×)Notable
Price-to-book: 0.40Industry median: 2.05Industry P5: 0.52Peers compared: 31.00
Financial Health
Altman Z-Score 0.7: distress zoneCritical
Altman Z-Score: 0.70
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Revenue is $1.81B, above the global median of $520.53MNotable
Revenue (USD): 1,812,960,139.622Global Median: 520,528,949.311
Levered free cash flow is $33.61M, above the global median of $16.24MNotable
Levered free cash flow (USD): 33,609,144.913Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Tianjin Jiuri New Materials Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Liaoning Dingjide Petrochemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Maxic Technology Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Willing New Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Wpg Shanghai Smart Water Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Yongji Printing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Rayonier Advanced Materials Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Zhejiang Tengen Electrics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kalyon Gunes Teknolojileri Uretim A.S.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Angiodynamics Inc.
Tier 1ProductionThroughput-Bound ConversionRule